arrow
M

María Poca

department of gastro-enterology
H指数:21
被引数:4,142

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the Perspectives, Knowledge and Attitudes Toward the “MASH-Cardiovascular Multidisciplinary Programme” of Subjects With Metabolic Dysfunction-Associated Steatohepatitis: A Qualitative Case Study Protocol

探索代谢功能障碍相关脂肪性肝炎患者对“MASH-心血管多学科项目”的视角、知识和态度:一项定性案例研究方案

2026-06-250
PRE
Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis
2026-01-270
OAAI
A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention

采用宏基因组学方法研究接受多因素干预的肝硬化患者中的虚弱问题

2025-11-010
OAAI
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Z.M.; de Avila, L.; Petta, S.; Hagström, H.; Kim, S.U.; Nakajima, A.; Crespo, J.; Castera, L.; Alkhouri, N.; Zheng, M.H.; 等. MASLD的纤维化、临床事件及死亡率的预测因素:全球MASLD研究的数据. 肝病学 2025. [Google Scholar] [CrossRef]

2025-11-013
PRE
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practice

定义非侵入性标准以在临床实践中指示代谢相关脂肪性肝病中的药物治疗

2025-09-020
PRE
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes

进一步失代偿对失代偿期肝硬化临床阶段生存率的影响: 门脉高压和HVPG变化的作用

2024-04-182
PRE
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

生化模式定义了与不同组织学和预后相关的MASLD表型

2024-04-151
OAAI
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

人工智能生成的模型预测酒精相关性肝炎的90天生存率: 一项全球队列研究

2024-04-123
PRE
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
2023-08-0112
OAAI
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

代谢组学作为预测代偿期肝硬化患者失代偿或肝脏相关死亡风险的工具

2023-02-235
PRE
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)
2022-03-0730
OAAI
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

血清miR-181b-5p预测代偿期肝硬化患者腹水发作

2021-12-017
OAAI
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

确定严重酒精相关性肝炎使用类固醇的最佳治疗窗口: 一项全球研究

2021-11-0175
OAAI